Skip to main content

Advertisement

Table 2 Minimal recurrent regions altered in MPNSTs (n = 7)

From: DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH

Cytoband Aberration Start clone End clone Size (Mb) Frequency Observation
1q21.1 Gain RP3-365I19 RP11-544O24 1.2 3/7 1 sample with +1q
1q24.1-q24.2 Gain RP11-525G13 RP4-780M13 3.7 5/7 1 sample with +1q
1q24.3-q25.1 Gain RP1-127D3 RP5-830A10 3.5 5/7 1 sample with +1q
2p15-p14 Gain RP11-52F10 RP11-263L17 3.0 3/7 1 sample with +2p
2q11.2-q13 Gain RP11-451C2 RP11-368A17 11.0 4/7 1 sample with +2q
3p26.2-p25.1 Gain RP11-95E11 RP11-255O19 12.6 4/7 1 sample with +3, 1 sample with +3p
3p22.1-p21.1 Gain RP11-437N10 RP11-122D19 11.5 3/7 1 sample with +3, 1 sample with +3p
3q27.2-q29 Gain RP11-110C15 RP11-23M2 12.5 3/7 1 sample with +3
5p14.3 Gain RP11-28P24 RP11-374E21 2.0 3/7 1 sample with +5
5q34-q35.3 Gain CTC-320C6 RP11-281O15 15.2 4/7 1 sample with +5
6p22.1-p12.1 Gain RP11-373N24 RP11-472M19 28.1 3/7 1 sample with +6p
6p12.1-q12 Gain RP3-422B11 RP11-349P19 7.8 3/7 1 sample with +6p, 1 sample with +6q
7p21.2-p14.1 Gain RP11-512E16 RP5-1178G13 26.3 3/7 1 sample with +7
7q11.23-q21.11 Gain RP11-313P13 RP5-1057M1 7.4 4/7 1 sample with +7, 1 sample with +7q
8p23.1-p12 Gain RP11-540E4 RP11-473A17 22.9 5/7 2 samples with +8
8q11.23-q24.3 Gain RP11-53M11 RP5-1056B24 90.5 3/7 2 samples with +8
9p24.3-p23 Gain RP11-48M17 RP11-413D24 11.6 3/7 1 sample with +9p
9p22.3-p21.2 Loss RP11-490C5 RP11-20P5 12.8 3/7 2 samples with -9p
9q21.32-q22.33 Gain RP11-541F16 RP11-192E23 16.0 4/7  
9q34.11-q34.13 Gain RP11-202H3 RP11-143H20 1.0 5/7  
11p13 Loss RP1-316D7 RP4-607I7 1.5 4/7  
11q22.3-q23.1 Loss RP11-2I22 RP11-11N15 7.7 3/7  
11q23.2-q23.3 Loss RP11-212D19 RP11-142I2 7.0 3/7  
12p13.32-p13.31 Gain RP11-543P15 RP11-277E18 4.8 3/7 1 sample with +12
12q12-q13.11 Gain RP11-333D23 RP11-89H19 9.3 3/7 1 sample with +12
12q13.3-q15 Gain RP11-474N8 RP11-101K2 14.2 4/7 1 sample with +12
12q21.2-q21.31 Gain RP11-26L7 RP11-268A19 3.3 3/7 1 sample with +12
12q22 Gain RP11-24I19 RP11-372G13 0.8 3/7 1 sample with +12
12q22-q23.3 Gain RP11-410A13 RP11-415D21 9.1 3/7 1 sample with +12
13q12.11-q12.12 Gain RP11-76K19 RP11-760M1 3.9 3/7 1 sample with +13
13q13.1-q14.3 Gain RP11-141M1 RP11-327P2 18.5 3/7 1 sample with +13
13q22.1-q22.2 Gain RP11-552M6 RP11-332E3 2.1 4/7 1 sample with +13
14q21.3-q23.3 Loss RP11-346L24 RP11-430G13 15.3 3/7  
14q24.3-q32.33 Gain RP11-61F4 RP11-417P24 27.9 3/7 1 sample with +14
16p13.3-p13.2 Gain RP11-344L6 RP11-148F10 7.9 4/7 2 samples with +16
16p13.12-p13.11 Gain RP11-82O18 RP11-489O1 0.9 4/7 2 samples with +16
16q21-q23.2 Gain RP11-148F12 RP11-437L22 18.2 3/7 2 samples with +16
17q23.2-q25.3 Gain RP11-112J9 RP11-567O16 26.2 5/7  
19p13.3-p13.2 Gain CTB-31C16 RP11-492L14 4.9 4/7 2 samples with +19p
22q12.3-q13.2 Gain LL22NC01-132D12 RP3-437M21 6.1 3/7